Sex-related differences in vitamin D testing in the Veneto Region, Italy: a retrospective analysis from 2005 to 2016.


Journal

Archives of osteoporosis
ISSN: 1862-3514
Titre abrégé: Arch Osteoporos
Pays: England
ID NLM: 101318988

Informations de publication

Date de publication:
30 Oct 2024
Historique:
received: 03 07 2024
accepted: 09 10 2024
medline: 31 10 2024
pubmed: 31 10 2024
entrez: 31 10 2024
Statut: epublish

Résumé

A retrospective analysis was performed to evaluate the frequency of vitamin D blood testing in individuals from the Padua province, Veneto, Italy from 2005 to 2016. A significant increase in the frequency of vitamin D blood tests, particularly in females was observed and in individuals with severe vitamin D deficiency (Class I). Vitamin D deficiency has been linked to negative health outcomes that extend beyond bone-related conditions. The frequency of vitamin D blood testing in residents from the Padua province, (Veneto, Italy) from 2005 to 2016 was evaluated. Data were retrospectively retrieved from blood test databases (Laboratory Medicine Unit, Padua University Hospital) and information on number of vitamin D blood tests performed on residents from 2005 to 2016 was collected. Data were stratified by sex and ten birth cohorts from 1901 to 2016. Blood tests were classified into five vitamin D classes: I < 50 nmol/L, II 50-74.9 nmol/L, III 75-149 nmol/L, IV 150-250 nmol/L, and V > 250-1000 nmol/L. Blood test trends were analyzed as blood test rate and vitamin D class rate/resident population. Population analysis was analyzed by incidence rates and stratified by vitamin D class. 293,013 vitamin D blood tests were conducted between 2005 and 2016 across 10 birth cohorts. Females accounted for 75% of tests and fewer were conducted in the youngest and oldest birth cohorts. Sex differences in vitamin D blood test frequency were observed; adjusted rates ranging from 1.7 to 35.6% for males and 8 to 81% for females from 2005 to 2016. Crude incidence rates (per 1000 from 2005 to 2016) varied from 1.5 to 10.8‰ for males and 7 to 19.4‰ for females. Crude blood test rates for vitamin D deficiency (Class I) increased from 1.1 to 9.9‰ in 2016 for males and 5 to 17.3‰ for females. Crude incidence rates (from 2005 to 2016) for Class I were 9.7-57.1‰ in males and 43.6-92.4‰ in females. These findings highlight sex-related differences in vitamin D testing, providing valuable insight for healthcare planning.

Identifiants

pubmed: 39477860
doi: 10.1007/s11657-024-01460-w
pii: 10.1007/s11657-024-01460-w
doi:

Substances chimiques

Vitamin D 1406-16-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105

Informations de copyright

© 2024. The Author(s).

Références

Kennel KA, Drake MT, Hurley DL (2010) Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc 85:752–758. https://doi.org/10.4065/mcp.2010.0138
doi: 10.4065/mcp.2010.0138 pubmed: 20675513 pmcid: 2912737
Jakobsen J, Smith C, Bysted A, Cashman KD (2019) Vitamin D in wild and farmed Atlantic salmon (Salmo Salar)—what do we know? Nutrients 11:982. https://doi.org/10.3390/nu11050982
doi: 10.3390/nu11050982 pubmed: 31036792 pmcid: 6566758
Aoun A, Maalouf J, Fahed M, El Jabbour F (2020) When and how to diagnose and treat vitamin D deficiency in adults: a practical and clinical update. J Diet Suppl 17:336–354. https://doi.org/10.1080/19390211.2019.1577935
doi: 10.1080/19390211.2019.1577935 pubmed: 30955384
DeLuca HF (2016) Chapter one - vitamin D: historical overview. In: Litwack G (ed) Vitamins & Hormones. Academic Press, pp 1–20
Sempos CT, Heijboer AC, Bikle DD, et al (2018) Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D. Br J Clin Pharmacol 84:2194–2207. https://doi.org/10.1111/bcp.13652
Bouillon R, Marcocci C, Carmeliet G et al (2019) Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr Rev 40:1109–1151. https://doi.org/10.1210/er.2018-00126
doi: 10.1210/er.2018-00126 pubmed: 30321335
Khundmiri SJ, Murray RD, Lederer E (2016) PTH and vitamin D. In: Comprehensive Physiology. American Cancer Society. 561–601
Charoenngam N, Shirvani A, Holick MF (2019) Vitamin D for skeletal and non-skeletal health: what we should know. J Clin Orthop Trauma 10:1082–1093. https://doi.org/10.1016/j.jcot.2019.07.004
doi: 10.1016/j.jcot.2019.07.004 pubmed: 31708633 pmcid: 6834997
Holick MF (2010) The vitamin D deficiency pandemic: a forgotten hormone important for health. Public Health Rev 32:267–283. https://doi.org/10.1007/BF03391602
doi: 10.1007/BF03391602
Bischoff-Ferrari HA, Orav EJ, Abderhalden L et al (2019) Vitamin D supplementation and musculoskeletal health. Lancet Diabetes Endocrinol 7:85. https://doi.org/10.1016/S2213-8587(18)30347-4
doi: 10.1016/S2213-8587(18)30347-4 pubmed: 30683217
Bouillon R, Lips P, Bilezikian JP (2019) Vitamin D supplementation and musculoskeletal health. Lancet Diabetes Endocrinol 7:85–86. https://doi.org/10.1016/S2213-8587(18)30348-6
doi: 10.1016/S2213-8587(18)30348-6 pubmed: 30683216
Ebeling PR, Adler RA, Jones G et al (2018) Management of endocrine disease: therapeutics of vitamin D. Eur J Endocrinol 179:R239–R259. https://doi.org/10.1530/EJE-18-0151
doi: 10.1530/EJE-18-0151 pubmed: 30131372
Degli Esposti L, Girardi A, Saragoni S et al (2019) Use of antiosteoporotic drugs and calcium/vitamin D in patients with fragility fractures: impact on re-fracture and mortality risk. Endocrine 64:367–377. https://doi.org/10.1007/s12020-018-1824-9
doi: 10.1007/s12020-018-1824-9 pubmed: 30515678
Giustina A, Adler RA, Binkley N et al (2019) Controversies in vitamin D: summary statement from an international conference. J Clin Endocrinol Metab 104:234–240. https://doi.org/10.1210/jc.2018-01414
doi: 10.1210/jc.2018-01414 pubmed: 30383226
Adami S, Giannini S, Bianchi G et al (2009) Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 20:239–244. https://doi.org/10.1007/s00198-008-0650-y
doi: 10.1007/s00198-008-0650-y
Agenzia Italiana del Farmaco (AIFA) Gazzetta ufficiale. In: Nota 79-Prescr. Osteoporos. Medicat. Risk Fragility Fract. Subseq. Fract. Internet. https://www.gazzettaufficiale.it/eli/id/2015/05/20/15A03762/sg . Accessed 30 Oct 2023
Manson JE, Cook NR, Lee I-M et al (2019) Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med 380:33–44. https://doi.org/10.1056/NEJMoa1809944
doi: 10.1056/NEJMoa1809944 pubmed: 30415629
Seraphin G, Rieger S, Hewison M et al (2023) The impact of vitamin D on cancer: a mini review. J Steroid Biochem Mol Biol 231:106308. https://doi.org/10.1016/j.jsbmb.2023.106308
doi: 10.1016/j.jsbmb.2023.106308 pubmed: 37054849 pmcid: 10330295
Vacek JL, Vanga SR, Good M et al (2012) Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol 109:359–363. https://doi.org/10.1016/j.amjcard.2011.09.020
doi: 10.1016/j.amjcard.2011.09.020 pubmed: 22071212
Pittas AG, Kawahara T, Jorde R et al (2023) Vitamin D and risk for type 2 diabetes in people with prediabetes. Ann Intern Med 176:355–363. https://doi.org/10.7326/M22-3018
doi: 10.7326/M22-3018 pubmed: 36745886
Kriegel MA, Manson JE, Costenbader KH (2011) Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin Arthritis Rheum 40:512-531.e8. https://doi.org/10.1016/j.semarthrit.2010.07.009
doi: 10.1016/j.semarthrit.2010.07.009 pubmed: 21047669
Eyles DW, Burne THJ, McGrath JJ (2013) Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol 34:47–64. https://doi.org/10.1016/j.yfrne.2012.07.001
doi: 10.1016/j.yfrne.2012.07.001 pubmed: 22796576
Schöttker B, Ball D, Gellert C, Brenner H (2013) Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res Rev 12:708–718. https://doi.org/10.1016/j.arr.2012.02.004
doi: 10.1016/j.arr.2012.02.004 pubmed: 22343489
Tripepi G, Fusaro M, Arcidiacono G et al (2023) Evaluating benefit from vitamin D supplementation: defining the area for treatment. Osteoporos Int 34:1531–1533. https://doi.org/10.1007/s00198-023-06802-x
doi: 10.1007/s00198-023-06802-x pubmed: 37243726
Demay MB, Pittas AG, Bikle DD, et al (2024) Vitamin D for the prevention of disease: an endocrine society clinical practice guideline. J Clin Endocrinol Metab dgae290. https://doi.org/10.1210/clinem/dgae290
Tuckey RC, Cheng CYS, Slominski AT (2019) The serum vitamin D metabolome: what we know and what is still to discover. J Steroid Biochem Mol Biol 186:4–21. https://doi.org/10.1016/j.jsbmb.2018.09.003
doi: 10.1016/j.jsbmb.2018.09.003 pubmed: 30205156
Mithal A, Wahl DA, Bonjour J-P et al (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA 20:1807–1820. https://doi.org/10.1007/s00198-009-0954-6
doi: 10.1007/s00198-009-0954-6
Kyriakaki A, Fragkoulis E (2019) The vitamin D paradox: high prevalence of deficiency in sunny Athens (Greece). Ann Res Hosp 3. https://doi.org/10.21037/arh.2019.06.02
Isaia G, Giorgino R, Rini GB et al (2003) Prevalence of hypovitaminosis D in elderly women in Italy: clinical consequences and risk factors. Osteoporos Int 14:577–582. https://doi.org/10.1007/s00198-003-1390-7
doi: 10.1007/s00198-003-1390-7 pubmed: 12856111
Müskens JLJM, Kool RB, van Dulmen SA et al (2023) Trends in number of vitamin B12- and D-determinations in the Netherlands. Ned Tijdschr Geneeskd 167:D7108
pubmed: 36920294
Crowe FL, Jolly K, MacArthur C et al (2019) Trends in the incidence of testing for vitamin D deficiency in primary care in the UK: a retrospective analysis of The Health Improvement Network (THIN), 2005–2015. BMJ Open 9:e028355. https://doi.org/10.1136/bmjopen-2018-028355
doi: 10.1136/bmjopen-2018-028355 pubmed: 31167871 pmcid: 6561453
Bilinski K, Boyages S (2013) Evidence of overtesting for vitamin D in Australia: an analysis of 4.5 years of Medicare Benefits Schedule (MBS) data. BMJ Open 3:e002955. https://doi.org/10.1136/bmjopen-2013-002955
Caillet P, Goyer-Joos A, Viprey M, Schott A-M (2017) Increase of vitamin D assays prescriptions and associated factors: a population-based cohort study. Sci Rep 7:10361. https://doi.org/10.1038/s41598-017-10263-8
doi: 10.1038/s41598-017-10263-8 pubmed: 28871163 pmcid: 5583252
Huber CA, Nagler M, Rosemann T et al (2020) Trends in micronutrient laboratory testing in Switzerland: a 7-year retrospective analysis of healthcare claims data. Int J Gen Med 13:1341–1348. https://doi.org/10.2147/IJGM.S275406
doi: 10.2147/IJGM.S275406 pubmed: 33293852 pmcid: 7719331
Sempos CT, Vesper HW, Phinney KW et al (2012) Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Investig Suppl 243:32–40. https://doi.org/10.3109/00365513.2012.681935
doi: 10.3109/00365513.2012.681935
Tripepi G, Jager KJ, Dekker FW, Zoccali C (2010) Stratification for confounding–part 2: direct and indirect standardization. Nephron Clin Pract 116:c322-325. https://doi.org/10.1159/000319591
doi: 10.1159/000319591 pubmed: 20664287
Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19:335–351. https://doi.org/10.1002/(sici)1097-0258(20000215)19:3%3c335::aid-sim336%3e3.0.co;2-z
doi: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z pubmed: 10649300
National Cancer Institute Joinpoint Regression Program
Passeri G, Giannini S (2023) Benefits of vitamin D in health and diseases. Nutrients 15:2419. https://doi.org/10.3390/nu15112419
doi: 10.3390/nu15112419 pubmed: 37299383 pmcid: 10254656
Bertoldo F, Cianferotti L, Di Monaco M et al (2022) Definition, assessment, and management of vitamin D inadequacy: suggestions, recommendations, and warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS). Nutrients 14:4148. https://doi.org/10.3390/nu14194148
doi: 10.3390/nu14194148 pubmed: 36235800 pmcid: 9573415
Hernlund E, Svedbom A, Ivergård M et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. Arch Osteoporos 8:136. https://doi.org/10.1007/s11657-013-0136-1
doi: 10.1007/s11657-013-0136-1 pubmed: 24113837 pmcid: 3880487
Ministero della Salute Osteoporosi. https://www.salute.gov.it/portale/nutrizione/dettaglioContenutiNutrizione.jsp?lingua=italiano&id=5504&area=nutrizione&menu=vuoto . Accessed 5 Nov 2023
Piscitelli P, Brandi M, Cawston H et al (2014) Epidemiological burden of postmenopausal osteoporosis in Italy from 2010 to 2020: estimations from a disease model. Calcif Tissue Int 95:419–427. https://doi.org/10.1007/s00223-014-9910-3
doi: 10.1007/s00223-014-9910-3 pubmed: 25200337
Statistiche Istat. http://dati.istat.it/Index.aspx . Accessed 31 May 2019
Degli Esposti L, Saragoni S, Perrone V et al (2020) Economic burden of osteoporotic patients with fracture: effect of treatment with or without calcium/vitamin D supplements. Nutr Diet Suppl 12:21–30. https://doi.org/10.2147/NDS.S234911
doi: 10.2147/NDS.S234911
Isgin-Atici K, Alathari BE, Turan-Demirci B et al (2022) Interaction between dietary fat intake and metabolic genetic risk score on 25-hydroxyvitamin D concentrations in a Turkish adult population. Nutrients 14:382. https://doi.org/10.3390/nu14020382
doi: 10.3390/nu14020382 pubmed: 35057563 pmcid: 8778439
Zhang Y, Xue Y, Zhang D et al (2021) Effect of vitamin D supplementation on glycemic control in prediabetes: a meta-analysis. Nutrients 13:4464. https://doi.org/10.3390/nu13124464
doi: 10.3390/nu13124464 pubmed: 34960022 pmcid: 8707376
Silveira EA, de Cardoso CK, S, Moura L de AN e, et al (2021) Serum and dietary vitamin D in individuals with Class II and III obesity: prevalence and association with metabolic syndrome. Nutrients 13:2138. https://doi.org/10.3390/nu13072138
doi: 10.3390/nu13072138 pubmed: 34206539 pmcid: 8308482
Sipos M, Péterffy B, Sziva RE et al (2021) Vitamin D deficiency cause gender specific alterations of renal arterial function in a rodent model. Nutrients 13:704. https://doi.org/10.3390/nu13020704
doi: 10.3390/nu13020704 pubmed: 33671779 pmcid: 7926839
Giannini S, Giusti A, Minisola S et al (2022) The immunologic profile of vitamin D and its role in different immune-mediated diseases: an expert opinion. Nutrients 14:473. https://doi.org/10.3390/nu14030473
doi: 10.3390/nu14030473 pubmed: 35276834 pmcid: 8838062
Giannini S, Passeri G, Tripepi G et al (2021) Effectiveness of in-hospital cholecalciferol use on clinical outcomes in comorbid COVID-19 patients: a hypothesis-generating study. Nutrients 13:219. https://doi.org/10.3390/nu13010219
doi: 10.3390/nu13010219 pubmed: 33466642 pmcid: 7828675
Giustina A, Bouillon R, Dawson-Hughes B et al (2023) Vitamin D in the older population: a consensus statement. Endocrine 79:31–44. https://doi.org/10.1007/s12020-022-03208-3
doi: 10.1007/s12020-022-03208-3 pubmed: 36287374
Muscogiuri G, Barrea L, Somma CD, et al (2019) Sex differences of vitamin D status across BMI classes: an observational prospective cohort study. Nutrients 11. https://doi.org/10.3390/nu11123034
De Martinis M, Sirufo MM, Polsinelli M et al (2021) Gender differences in osteoporosis: a single-center observational study. World J Mens Health 39:750–759. https://doi.org/10.5534/wjmh.200099
doi: 10.5534/wjmh.200099 pubmed: 33474849
Sutherland JP, Zhou A, Hyppönen E (2022) Vitamin D deficiency increases mortality risk in the UK Biobank : a nonlinear Mendelian randomization study. Ann Intern Med 175:1552–1559. https://doi.org/10.7326/M21-3324
doi: 10.7326/M21-3324 pubmed: 36279545
Lv Q-B, Gao X, Liu X et al (2017) The serum 25-hydroxyvitamin D levels and hip fracture risk: a meta-analysis of prospective cohort studies. Oncotarget 8:39849–39858. https://doi.org/10.18632/oncotarget.16337
doi: 10.18632/oncotarget.16337 pubmed: 28418890 pmcid: 5503658
Singer AG, McChesney C (2023) Reduce unnecessary routine vitamin D testing. Can Fam Physician Med Fam Can 69:620–622. https://doi.org/10.46747/cfp.6909620
doi: 10.46747/cfp.6909620

Auteurs

Sandro Giannini (S)

Clinica Medica 1, Department of Medicine, University of Padova, Padua, Italy.

Annalisa Pitino (A)

Institute of Clinical Physiology (IFC), National Research Council (CNR), Rome, Italy.

Stefania Sella (S)

Clinica Medica 1, Department of Medicine, University of Padova, Padua, Italy.

Maria Fusaro (M)

Clinica Medica 1, Department of Medicine, University of Padova, Padua, Italy. dante.lucia11@gmail.com.
Institute of Clinical Physiology (IFC), National Research Council (CNR), Pisa, Italy. dante.lucia11@gmail.com.

Gaetano Paride Arcidiacono (GP)

Clinica Medica 1, Department of Medicine, University of Padova, Padua, Italy.

Marco Onofrio Torres (MO)

Clinica Medica 1, Department of Medicine, University of Padova, Padua, Italy.

Martina Zaninotto (M)

QI.Lab.Med, Spin-off of the University of Padova, Padua, Italy.

Mercedes Gori (M)

Institute of Clinical Physiology (IFC), National Research Council (CNR), Rome, Italy.

Andrea Aghi (A)

Clinica Medica 1, Department of Medicine, University of Padova, Padua, Italy.

Colin Gerard Egan (CG)

CE Medical Writing SRLS, Pisa, Italy.

Paolo Simioni (P)

Clinica Medica 1, Department of Medicine, University of Padova, Padua, Italy.

Giovanni Tripepi (G)

Institute of Clinical Physiology (IFC), National Research Council (CNR), Reggio Calabria, Italy.

Mario Plebani (M)

QI.Lab.Med, Spin-off of the University of Padova, Padua, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH